Dexmedetomidine for neurological surgery

Neurosurgery

Volumn 57, Issue 1 SUPPL., 2005, Pages

  Bekker, Alex ^a   Sturaitis, Mary K ^b,c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RUSH MEDICAL COLLEGE   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

2 Adrenoreceptor agonist; Cerebral blood flow; Dexmedetomidine; Neuroanesthesia; Neuromonitoring; Neurophysiology; Sedation

Indexed keywords

4 AMINOBUTYRIC ACID; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 2C ADRENERGIC RECEPTOR; ATIPAMEZOLE; BENZODIAZEPINE; CLONIDINE; DEXMEDETOMIDINE; PROPOFOL; XYLAZINE;

ANALGESIA; ASYSTOLE; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; CARDIOVASCULAR EFFECT; CLINICAL TRIAL; DIURESIS; DOSE RESPONSE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INHIBITION; ELECTROENCEPHALOGRAPHY; EVOKED RESPONSE; HUMAN; INTENSIVE CARE UNIT; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; LOCUS CERULEUS; LUNG VENTILATION; NEUROPHARMACOLOGY; NEUROPHYSIOLOGY; NEUROPROTECTION; NEUROSURGERY; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY FUNCTION; REVIEW; SEDATION; SEIZURE; SPINE SURGERY; TRANQUILIZING ACTIVITY;

ADRENERGIC ALPHA-AGONISTS; ANALGESICS, NON-NARCOTIC; BRAIN; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS; DEXMEDETOMIDINE; HUMANS; HYPNOTICS AND SEDATIVES; INTRAOPERATIVE CARE; NEUROSURGICAL PROCEDURES; RECEPTORS, ADRENERGIC, ALPHA-2;

EID: 21744458386     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000163476.42034.A1     Document Type: Review

References (98)

1. Arain SR, Ruehlow RM, Uhrich TD, Ebert TJ: The efficacy of dexmedetomidine versus morphine for postoperative analgesia after major inpatient surgery. Anesth Analg 98:153-158, 2004.
2. Ard J, Doyle W, Bekker A: Awake craniotomy with dexmedetomidine in pediatric patients. J Neurosurg Anesthesiol 15:263-266, 2003.
3. Ard J, Doyle W, Bekker A: Dexmedetomidine in awake craniotomy: A technical note. Surg Neurol 63:114-117, 2005.
4. 2 receptor subtypes. J Neurosci 8:4287-4298, 1988.
5. 2-adrenergic agonist dexmedetomidine in the rat. Am J Physiol 272[Suppl 6]:H2547-H2556, 1997.
6. Ayajiki K, Toda N: Isolated bovine cerebral arteries from rostral and codal regions: Distinct responses to adrenoceptor agonists. Eur J Pharmacol 191: 417-425, 1990.
7. Bai-Han Li, Lohmann JS, Schuler H, et al.: Preservation of the cortical somatosensory-evoked potential during dexmedetomidine infusion in rats. Anesth Analg 96:1155-1160, 2003.
8. Basali A, Mascha E, Kalfas I, Schubert A: Relation between perioperative hypertension and intracranial hemorrhage after craniotomy. Anesthesiology 93:48-54, 2000.
9. Bekker A, Basile J, Gold M, Riles T, Adelman M, Cuff G, Mathew JD, Goldberg JD: Dexmedetomidine for awake carotid endarterectomy: Efficacy, hemodynamic profile, and side effects. J Neurosurg Anesthesiol 16:126-135, 2004.
10. Bekker A, Gold M, Basile J, et al.: Hemodynamic and respiratory changes related to the use of dexmedetomidine in patients undergoing awake carotid endarterectomy. Anesthesiology 100:A136, 2003.
11. Bekker A, Kaufman B, Samir H, Doyle W: The use of dexmedetomidine infusion for awake craniotomy. Anesth Analg 92:1251-1253, 2001.
12. Belleville JP, Ward DS, Bloor BC, Maze M: Effects of intravenous dexmedetomidine in humans: Part I-Sedation, ventilation, and metabolic rate. Anesthesiology 77:1125-1133, 1992.
13. Berridge CW, Waterhouse BD: The locus coeruleus-noradrenergic system: Modulation of behavioral state and state-dependent cognitive processes. Brain Res Brain Res Rev 42:33-84, 2003.
14. Bischoff P, Mahlstedt D, Blanc I, Schulte am Esch J: Quantitative topographical electroencephalographic analysis after intravenous clonidine in healthy male volunteers. Anesth Analg 86:202-207, 1998.
15. Bloom M, Beric A, Bekker A: Dexmedetomidine infusion and somatosensory evoked potentials. J Neurosurg Anesthiol 13:320-322, 2001.
16. Bloor BC, Ward DS, Belleville JP, Maze M: Effects of intravenous dexmedetomidine in humans: Part II-Hemodynamic changes. Anesthesiology 77:1134-1142, 1992.
17. Bramanti P, Mariani CA, D'Aleo G, Malara A: The first in vivo experience of the effects of the continuous intrathecal infusion of clonidine on the locus coeruleus in the regulation of cerebral blood flow: A TCD study. Ital J Neurol Sci 18:139-144, 1997.
18. 2-adrenoceptors in pial arteries of anesthetized newborn pigs. Dev Pharmacol Ther 10:36-46, 1987.
19. 2-Adrenoreceptor subtypes. Pharmacolog Res 44:195-208, 2001.
20. Chadha R, Padmanabhan V, Joseph A, Mohandas K: Oral clonidine pre-treatment for hemodynamic stability during craniotomy. Anaesth Intensive Care 20:341-344, 1992.
21. Changani S, Papadakos P: The use of dexmedetomidine for sedation in patients with traumatic brain injury. Anesthesiology [Supplement, ASC-CA]:B20, 2002.
22. Chen Y, Zhao Z, Code WE, Hertz L: A correlation between dexmedetomidine-induced biphasic increases in free cytosolic calcium concentration and energy metabolism in astrocytes. Anesth Analg 91:353-357, 2000 (abstr).
23. Cohen Z, Molinatti G, Hamel E: Astroglial and vascular interactions of noradrenaline terminals in the rat cerebral cortex. J Cereb Blood Flow Metab 17:894-904, 1997.
24. Costello TG, Cormack JR: Clonidine premedication decreases hemodynamic responses to pin head-holder application during craniotomy. Anesth Analg 86:1001-1004, 1998.
25. 2 noradrenergic system: Effects on cognition. Drugs Aging 5:116-126, 1994.
26. Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD: The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 93:382-394, 2000.
27. 2 agonists and analgesia. Exp Opin Invest Drugs 3:1005-1010, 1994.
28. 2 agonist dexmedetomidine on cerebral neurotransmitter concentrations during cerebral ischemia in rats. Anesthesiology 96:450-457, 2002.
29. +-ketamine on the expression of apoptosis-regulating proteins after incomplete cerebral ischemia and reperfusion in rats. Anesth Analg 96:524-531, 2003.
30. 2-Adrenergic agonist effects on normocapnic and hypercapnic cerebral blood flow in the dog are anesthetic dependent. Anesth Analg 79:892-898, 1994.
31. Farber N, Poterack K, Schmelling W: Dexmedetomidine and halothane produce similar alterations in electroencephalographic and electromyographic activity in cats. Brain Res 774:131-141, 1997.
32. Favre JB, Gardaz JP, Ravussin P: Effect of clonidine on ICP and on the hemodynamic responses to nociceptive stimuli in patients with brain tumors. J Neurosurg Anesthesiol 7:159-167, 1995.
33. Ferrari-DiLeo G, Potter LT: α-adrenoceptors and muscarinic receptors in human pial arteries and microvessels: A receptor binding study. J Cereb Blood Flow Metab 5:458-464, 1985.
34. Fogarty-Mack P, Perrine K, Kobylarz E, Schwartz TH, Lien CA: Dexmedetomidine and neurocognitive testing in awake craniotomy. J Neurosurg Anesthesiol 16:20-25, 2004.
35. Ganjoo P, Farber NE, Hudetz A, Smith JJ, Samso E, Kampine JP, Schmeling WT: In vivo effects of dexmedetomidine on laser Doppler flow and pial arteriolar diameter. Anesthesiology 88:429-439, 1998.
36. Gateia P, Staplefeldt C, Talke P: Effect of dexmedetomidine on eleptiform discharges in adults with medically refractory epilepsy. Epilepsia 45(S7):60, 2004 (abstr).
37. 2 receptors. Am J Physiol 259:F1-F8, 1990.
38. Globus MY, Busto R, Dietrich WD, Martinez E, Valdes I, Ginsberg MD: Direct evidence for acute and massive norepinephrine release in the hippocampus during transient ischemia. J Cereb Blood Flow Metab 9:892-896, 1989.
39. Hall JE, Uhrich TD, Barney JA, Arain SR, Ebert TJ: Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg 90:699-705, 2000.
40. Hodgson PS, Liu SS: New developments in spinal anesthesia. Anesthesiol Clin North America 18:235-249, 2000.
41. 2-adrenergic antagonist atipamezole. Anesthesiology 75:328-332, 1991.
42. Huang R, Chen Y, Yu AC, Hertz L: Dexmedetomidine-induced stimulation of glutamine oxidation in astrocytes: A possible mechanism for its neuroprotective activity. J Cereb Blood Flow Metab 20:895-898, 2000.
43. Ishiyama T, Dohi S, Iida H, Watanabe Y, Shimonaka H: Mechanisms of dexmedetomidine-induced cerebrovascular effects in canine in vivo experiments. Anesth Analg 81:1208-1215, 1995.
44. 2-adrenoceptor agonist-in healthy volunteers. Pain 46:281-285, 1991.
45. Jorden V, Herr D: Characterization and management dexmedetomidine-related hypotension following CABG. Crit Care Med 31:A157-A621, 2003 (abstr).
46. 2-adrenergic agonists. Anesthesiology 93:1345-1349, 2000.
47. 2-agonist, on cerebral blood flow and oxygen consumption during halothane anesthesia in dogs. Anesth Analg 71:125-129, 1991.
48. 2 and imidazoline receptor agonists: Their pharmacology and therapeutic role. Anaesthesia 54:146-165, 1999.
49. Kuhmonen J, Haapalinna A, Sivenius J: Effects of dexmedetomidine after transient and permanent occlusion of the middle cerebral artery in the rat. J Neural Transm 108:261-271, 2001.
50. Kuhmonen J, Pokorny J, Miettinen R, Haapalinna A, Jolkkonen J, Riekkinen P, Sivenius J: Neuroprotective effects of dexmedetomidine in the gerbil hippocampus after transient global ischemia. Anesthesiology 87:371-377, 1997.
51. 2 reactivity and cerebral autoregulation in healthy volunteers. Anesthesiology 95(3A):A341, 2001 (abstr).
52. 2-adrenoceptor agonists on perinatal excitoxic brain injury: Comparison of clonidine and dexmedetomidine. Anesthesiology 96:134-141, 2002.
53. Lawrence CJ, Prinzen FW, de Lange S: The effect of dexmedetomidine on the balance of myocardial energy requirement and oxygen supply and demand. Anesth Analg 82:544-550, 1996.
54. Lee HW, Caldwell J, Dodson B, Talke P, Howley J: The effect of clonidine on cerebral blood flow velocity, carbon dioxide cerebral vasoreactivity, and response to increased arterial pressure in human volunteers. Anesthesiology 87:553-558, 1997.
55. Lotto M, Bahtia S, Ebrahim Z, et al.: Successful cognitive testing in patients undergoing awake craniotomy with dexmedetomidine and propofol sedation. Anesthesiology 100(3A):A356, 2003 (abstr).
56. 2-adrenoceptor agonist dexamedetomidine in a focal model of cerebral ischemia. Anesthesiology 79:306-312, 1993.
57. 2-adrenoceptor agonist dexmedetomidine in postsurgical sedation in the intensive care unit. J Intensive Care Med 18:29-41, 2003.
58. Maze M, Scarfini C, Cavaliere F: New agents for sedation in the intensive care unit. Crit Care Clin 17:881-897, 2001.
59. Maze M, Virtanen R, Daunt D, Banks SJ, Stover EP, Feldman D: Effects of dexmedetomidine, a novel imidazole sedative-anesthetic agent, on adrenal steroidogenesis: In vivo and in vitro studies. Anesth Analg 73:204-208, 1991.
60. 2 adrenergic inhibition of sympathetic ganglionic transmission. Anesth Analg 87:503-510, 1998.
61. 2 adrenoreceptor agonist after subarachnoid hemorrhage. Neurosurgery 32:974-979, 1993.
62. 2 adrenergic, and nitric oxide-dependent interactions on canine cerebral blood flow. Am J Physiol 226[Suppl 2]:H476-H482, 1994.
63. 2 adrenoreceptors in the rostral ventrolateral medulla evokes natriuresis by a renal nerve mechanism. Am J Physiol 218:R98-R101, 2001.
64. Mirski MA, Rossell LA, McPherson RW, Traystman RJ: Dexmedetomidine decreases seizure threshold in a rat model of experimental generalized epilepsy. Anesthesiology 81:1422-1428, 1994.
65. Miyazaki Y, Adachi T, Kurata J, Utsumi J, Shichino T, Segawa H: Dexmedetomidine reduces seizure threshold during enflurane anesthesia in cats. Br J Anesth 82:935-937, 1999.
66. Deleted in proof.
67. Nelson L, Maze M: Neural substrates for behavior: Consciousness, in Evers A, Maze M (eds): Anesthetic Pharmacology. Burlington, Elsevier, 2004, pp 227-243.
68. Ohata H, Iida H, Dohi S, Watanabe Y: Intravenous dexmedetomidine inhibits cerebrovascular dilation induced by isoflurane and sevoflurane in dogs. Anesth Analg 89:370-377, 1999.
69. Prielipp RC, Wall MH, Tobin JR, Groban L, Cannon MA, Fahey FH, Gage HD, Stump DA, James RL, Bennett J, Butterworth J: Dexmedetomidine-induced sedation in volunteers decreases regional and global blood flow. Anesth Analg 95:1052-1059, 2002.
70. Ramsey MA, Luterman DL: Dexmedetomidine as a total intravenous anesthestic agent. Anesthesiology 101:787-781, 2004.
71. Rasmussen K, Jacobs BL: Locus coeruleus unit activity in freely moving cats increased following systemic morphine administration. Brain Res 344:240-248, 1985.
72. Rozet I, Souter Mj, Domino K, et al.: Dexmedetomidine sedation for awake craniotomies. Anesthesiology 101(3A):A375, 2004 (abstr).
73. 2Adrenoreceptor Agonists in Anesthesia and Intensive Care. London, Bailliere Tindall, 2000, pp 247-260.
74. Sturaitis MK, Braverman B, Tuman KJ: Effect of dexmedetomidine on somatosensory evoked potentials in patients during craniotomy. Anesthesiology 99(3A):A291, 2003 (abstr).
75. Sturaitis MK, Ford EW, Palac SM, Smith MC, Tuman KJ: Effect of dexmedetomidine on operative conditions and electrocorticographic responses during asleep craniotomy for seizure focus resection. Epilepsia 44(S9):331, 2003 (abstr).
76. Sturaitis MK, Ford EW, Toleikis SC, Toleikis JR, Braverman B, Tuman KJ: Neurophysiologic monitoring of ophthalmic artery aneurysm surgery: Facilitating the use of flash electroretinograms (F-ERG) and visual evoked potentials (VEP). Anesthesiology 101(3A):A313, 2004 (abstr).
77. Sturaitis M, Kroin J, Swamidoss CS, et al.: Effect of intraoperative dexmedetomidine infusion on hemodynamic stability during brain tumor resection. Anesthesiology 97(3A):A310, 2002 (abstr).
78. 2) in patients undergoing cerebrovascular surgery. Anesth Analg 98:S139, 2004 (abstr)
79. Sturaitis M, Verhagen L, Bakay R: Deep Brain Stimulator Data Base, Departments of Anesthesiology, Neurology and Neurosurgery, Rush University Medical Center.
80. 2-adrenoreceptor agonists, in Scholz J, Tonner PH, (eds): Bailliere's Best Practice and Research: Clinical Anesthesiology-α2 Adrenoreceptor Agonists in Anesthesia and Intensive Care. London, Bailliere Tindall, 2000, pp 271-280.
81. Talke P, Bickler PE: Effects of dexmedetomidine on hypoxia-evoked glutamate release and glutamate receptor activity in hippocampal slices. Anesthesiology 85:551-557, 1996.
82. Talke P, Chen R, Thomas B, Aggarwall A, Gottlieb A, Thorborg P, Heard S, Cheung A, Son SL, Kallio A: The hemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery. Anesth Analg 90:834-839, 2000.
83. Talke P, Tong C, Lee HW, Caldwell J, Eisenach JC, Richardson CA: Effect of dexmedetomidine on lumbar cerebrospinal fluid pressure in humans. Anesth Analg 85:358-364, 1997.
84. ter Minassian A, Beydon L, Decq P, Bonnet F: Changes in cerebral hemodynamics after a single dose of clonidine in severely head-injured patients. Anesth Analg 84:127-132, 1997.
85. Thornton C, Lucas MA, Newton DE, Dore CJ, Jones RM: Effects of dexmedetomidine on isoflurane requirements in healthy volunteers: Part 2-Auditory and somatosensory evoked potentials. Br J Anaesth 83:381-386, 1999.
86. Traill R, Gillis R: Clonidine premedication for craniotomy: Effects on blood pressure and thiopentone dosage. J Neurosurg Anesthiol 5:171-177, 1993.
87. Ulrich K, Kuschinsky W: In vivo effects of α-adrenoreceptor agonists and antagonists on pial veins of cats. Stroke 16:880-884, 1985.
88. Urban MK, Wukovits B, Flynn E: Dexmedetomidine versus propofol for sedation of ventilated spinal patients. Anesthesiology 101(3A):A158, 2004 (abstr).
89. Venn RM, Grounds RN: Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: Patient and clinician perceptions. Br J Anaesth 87:684-690, 2001.
90. Venn RM, Bradshaw CJ, Spencer R, Brealey D, Caudwell E, Naughton C, Vedio A, Singer M, Feneck R, Treacher D, Willatts SM, Grounds RM: Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia 54:1136-1142, 1999.
91. Venn RM, Bryant A, Hall GM, Grounds RM: Effects of dexmedetomidine on adrenocortical function, and the cardiovascular, endocrine, and inflammatory responses in post-operative patients needing sedation in the intensive care unit. Brit J Anaesth 86:650-656, 2001.
92. Venn RM, Hell J, Grounds RM: Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Crit Care 4:302-308, 2000.
93. 2 adrenergic agonists to prevent perioperative cardiovascular complications: A meta-analysis. Am J Med 114:742-749, 2003.
94. 2-adrenoceptor agonist, on renal sympathetic nerve activity, blood pressure, heart rate and central venous pressure in urethane-anesthetized rabbits. J Auton Nerv Syst 72:48-54, 1998.
95. Yaksh TL, Pogrel JW, Lee YW, Chaplan SR: Reversal of nerve ligation-induced allodynia by spinal α-2 adrenoreceptor agonists. J Pharmacol Exp Ther 272:207-214, 1995.
96. 2-adrenergic agonist, decreases cerebral blood flow in the isoflurane-anesthetized dog. Anesth Analg 70:624-630, 1990.
97. Zornow MH, Maze M, Dyck JB, Shafer SL: Dexmedetomidine decreases cerebral blood flow velocity in humans. J Cereb Blood Flow Metab 13:350-353, 1993.
98. Zornow MH, Scheller MS, Sheehan PB, Strnat MA, Matsumoto M: Intracranial pressure effects of dexmedetomidine in rabbits. Anesth Analg 75:232-237, 1992.